Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Co-Circulation of Dengue Virus Type 3 Genotypes in Vientiane Capital, Lao PDR

Co-Circulation of Dengue Virus Type 3 Genotypes in Vientiane Capital, Lao PDR

  • Malayvanh Lao, 
  • Valérie Caro, 
  • Jean-Michel Thiberge, 
  • Phaitong Bounmany, 
  • Khamsing Vongpayloth, 
  • Philippe Buchy, 
  • Veasna Duong, 
  • Chansamone Vanhlasy, 
  • Jean-Marie Hospied, 
  • Manichanh Thongsna
PLOS
x

Abstract

During the 2012 epidemic of dengue in Vientiane capital, Lao PDR, a major serotype switch from dengue 1 to 3 was observed. A molecular epidemiology study demonstrated that dengue 3 remained the predominant serotype in 2013, but also revealed the co-circulation of two genotypes, supporting the hypothesis of multiple geographic origins of dengue 3 strains circulating in Vientiane capital.

Introduction

Dengue fever is the most important and rapidly spreading vector-borne viral disease in the tropics [1]. Despite important efforts for surveillance and prevention, large-scale epidemics frequently occur in endemic countries. Prediction of dengue epidemics based on serotype identification is a valuable approach only if a significant number of samples are analyzed over long periods of time [1], [2]. Intensive efforts to improve serotype surveillance and vector control in various islands in the Caribbean significantly improved dengue outbreak management [2]. In contrast, some South-East Asian countries, e.g., Thailand, Cambodia and Vietnam report a plethora of cases every year despite active serotype surveillance [3], [4]. In Lao Peoples' Democratic Republic, samples for dengue typing have been collected since 1987, but until now available data remained scarce [http://www.wpro.who.int/emerging_diseases/DengueWPRO20108Sep2011.pdf]. Since 2010, a robust complementary network has been set up in Vientiane capital to reinforce diagnostic capacities and to improve dengue surveillance [5]. This surveillance network allowed us to detect a switch from dengue virus (DENV) serotype 1 to 3 and to follow the progression and expansion of DENV-3 serotype and its genotypes during the 2012–2013 epidemics in Vientiane capital.

Methods

Sample collection

In Vientiane capital, from March 2012 to December 2013 a surveillance network, coordinated by the Institut Pasteur du Laos, investigated suspected dengue patients to determine dengue serotypes and genotypes. Suspected dengue cases were defined as patients who had undergone a medical consultation or were hospitalized in one of the partner clinical facilities in Vientiane who presented with sudden fever onset (≥38°C) for less than 7 days with at least one of the following accompanying symptoms: headache; myalgia; arthralgia; retro-orbital pain; digestive troubles or hemorrhaging. Patients included were either Lao nationals or expatriates, residing in Vientiane city or repatriated from provinces for medical reason and hospitalized in Vientiane. After obtaining informed consent, a 5 ml venous blood sample was taken from patients in hospitals or consultation facilities. Samples were stored at 4°C until transportation to the Institut Pasteur du Laos for analysis.

Ethics statement

The study protocol was approved by the National Ethic Committee for Health Research of the Ministry of Health of Lao PDR. All public hospitals' management committees approved the study and obtained the agreement of the Ministry of health for participating with the protocol.

All adult volunteers provided a written informed consent. A parent or legal guardian of any child included in the study signed a consent form on their behalf.

RT-PCR amplification

Samples were screened for dengue virus and serotypes were determined by a pan-dengue RT-PCR and specific real time RT-PCRs [6], [7].

Total viral RNA was extracted from the supernatant of C6/36 cultures inoculated with viremic human plasmas or directly from human plasmas. In addition, a DENV-3 strain, isolated from an autochthonous case in Vientiane capital in 2011 was analysed.

Extractions were carried out using NucleoSpin II RNA kit (Macherey Nagel) according to the manufacturer's instructions.

Envelope gene sequencing

Sequencing of the complete envelope (E) gene (1479 nt) was performed on sixty-two Lao isolates of DENV-3 (Table 1). Amplicons were generated using the Superscript One Step kit (Invitrogen). The one-step RT-PCR reaction was performed in a volume of 25 µL containing 2 µL RNA template, 7 µL ddH2O, 12.5 µL RT-PCR buffer (5X), 1 µL sense oligonucleotide (10 µM), 1 µL anti-sense oligonucleotide (10 µM), 0.5 µL DMSO and 1 µL enzyme mix. The following set of specific primers was used to produce 3 overlapping amplicons: Den3-1F 5′-AGT TGT TAG TCT ACG TG-3′, Den3-1013R 5′ GGT AGT CAC ACA CCC CCC GTG-3′, Den3-815F 5′-GCC CTT AGG CAC CCA GGG TT-3′, Den3-1752R 5′-CCC GCG AAA ATG CTT GTG C-3′, Den3-1398F 5′-CGC AAG GAG TCA CGG CTG AG-3′, Den3-2539R 5′-GCC TGC AAT GGC TGT TGC C-3′. The amplification program was performed as follows: reverse transcription at 50°C for 30 min, an inactivation of RT enzyme step at 94°C for 2 min, followed by 35 cycles of 94°C 15 s, 55°C 30 s, 72°C 1 min 30 s, and a final step at 72°C for 10 min. PCR products were purified using the NucleoFast kit (Macherey Nagel) as specified by the manufacturer. Sequencing was carried out using the BigDye Terminator Cycle Sequencing Ready Reaction kit version 1.1 (Applied Biosystems). The sequencing reaction was performed in a volume of 10 µL containing 2 µL PCR product template, 4 µL ddH2O, 1 µL sequencing buffer (5X), 1 µL oligonucleotide (4 µM) and 2 µL Big Dye version 1.1. The sequencing program was performed as follows: 96°C 1 min followed by 30 cycles of 96°C 10 s, 50°C 5 s, 60°C 1 min 15 s. Sequence chromatograms for both strands were obtained using an automated sequence analyzer ABI3730XL (Applied Biosystems).

Phylogenetic analysis

A total of 62 DENV-3 E gene sequences were used in this study. Nucleotides sequences of complete E genes of DENV-3 isolates used were submitted to EMBL-EBI and their accession numbers are shown in Table 1. The nucleotide sequences of complete E genes of Lao DENV isolates were aligned, edited, and analyzed using the software BioNumerics v 6.6 (Applied-Maths, Saint-Martens-Latem, Belgium).

For a comprehensive phylogenetic analysis, the data included 16 DENV-3 E sequences of Lao, PDR selected to be representative of the different provinces and covering the studied period and 25 closest reference strains of DENV-3, i.e. genotypes I, II, II and IV, obtained from GenBank.

Phylogenetic analyses, using maximum likelihood method, were conducted using MEGA version 6 (www.megasoftware.net). A maximum-likelihood tree was constructed based on the Tamura-Nei model. Sequence of DENV-3/Puerto Rico/1963 genotype IV (L11433) was used as an outgroup to root the tree. The robustness of nodes was assessed with 1,000 bootstrap replicates.

Results

Over a period of 21 months, a total of 2780 cases with a suspected dengue infection were recruited through our clinical network in Vientiane capital. The sex ratio was 1.03∶1 (50,7% males; 49,3% females) and the median age was 20 years (range: 5 months - 78 years). Most of the patients hospitalized were residents of Vientiane capital or suburban areas. A few cases were repatriated from provinces (Northern Lao PDR; n = 1; Oudomxai, n = 1; Luang Prabang, n = 2; Champasack, n = 2).

Longitudinal analysis revealed an early and efficient transmission of dengue virus in Vientiane capital during the dry season (November-April) preceding an increase of incidence during the dry season (May-September; Fig. 1A). More importantly, severe clinical presentations including fatal confirmed cases, were recorded during the dry season (data not shown). Over the period studied, 2780 samples from patients matching the case definition were investigated. Confirmation of dengue infection could be established by RT-PCR in a total of 1535 patients (55.2%). The rate of confirmation was significantly different, varying from 44.7% (227/507) in 2012 to 57.5% (1308/2273) in 2013.

thumbnail
Figure 1. Surveillance performed by Institut Pasteur du Laos from March 2012 to December 2013.

(A) Distribution of confirmed cases (i.e. RT-PCR and/or NS1 and/or culture positive) in Vientiane city (B). Dengue serotypes distribution in 2012 and 2013. Recording of dengue serotypes distribution on a four monthly basis. As the surveillance only started in late March 2012, partial data collected in April were not included in the figure.

https://doi.org/10.1371/journal.pone.0115569.g001

Exhaustive serotype determination by RT-PCR and/or sequencing was systematically carried out in 2012. In 2013, as the number of suspected cases in Vientiane dramatically increased, the real-time serotype surveillance was limited to a subset (≈10%) of the weekly confirmed cases.

Dengue serotype 1 (66%) and serotype 2 (33%) co-circulated from April to May 2012, but the exhaustive typing of positive samples revealed a sudden circulation and a high incidence of dengue serotype 3 in June 2012 (Fig. 1B). Since the end of June 2012, DENV-3 became the predominant serotype in circulation. DENV-3 circulation continued during the dry season (November to April 2013) with an increase in the proportion of DENV-3 up to 87%. From May to August 2013, DENV-3 incidence further increased up to 94%. DENV-4 ranged from ≤1% to 6% over the period studied.

A total of 62 isolates were sequenced and analyzed, corresponding to various foci of transmission and during different periods of DENV-3 circulation in Vientiane capital, (Table 1). For clarity, only a subset of 16 Lao DENV-3 envelope gene sequences representative of the different provinces and covering the studied period was used for phylogenetic analysis (Fig. 2). Sequences were compared to 25 reference sequences of different DENV-3 genotypes available in GenBank.

thumbnail
Figure 2. Phylogenetic relationships of DENV-3 based on the complete E nucleotide sequences (1479 nt) of 41 isolates, including 16 Lao isolates.

Blue triangles and blue circles represent Lao DENV-3 genotype II and III strains respectively. Sequence alignments were performed using BioNumerics version 6.6. A maximum-Likelihood tree was constructed using MEGA version 6, based on Tamura-Nei model. Bootstrap resampling values are indicated at major nodes. Scale bar indicates number of base substitutions per site.

https://doi.org/10.1371/journal.pone.0115569.g002

Among the four genotypes of DENV-3 (I-IV), the Lao DENV-3 fell into genotypes II and III appearing during two distinct periods. DENV-3 genotype II viruses were detected from June 2012 onwards, whereas genotype III viruses were only isolated since November 2012.

In this series, most of the Lao viruses (58 isolates) belonged to genotype II as for other Asian isolates recently described in Cambodia, Thailand and Vietnam. These Lao isolates shared 99.5% nucleotide identity (99.6% amino-acid identity) The homogeneity of this group was independent of the date and geographic distribution (up to 1200 km from the northern province Oudomxai to Champasak province in the south) suggesting a long lasting circulation of DENV-3 genotype II.

This group of Lao isolates is strongly related to strains from Myanmar isolated between 2005 and 2009 (99.2% nucleotide identity between the two groups) and form an independent cluster well supported by a high bootstrap value.

DENV-3 genotype III Lao isolates displayed 99.93% nucleotide identity between each other, and showed a close relationship with isolates from India (2005) and Bhutan (2007). The fact that genotype III was only identified after November 2012 in Vientiane Capital supports a recent introduction in the city from another Asian country.

Our data suggested that the introduction of genotype II and III were most likely independent and singular events.

Thus, this analysis indicates that at least two genotypes of DENV-3 co-circulate in the country, corresponding to the commonly observed genotype in this geographical area, with a current the predominance of genotype II. Further investigation on DENV-3 isolates from 2013 is ongoing to follow the evolution and dynamics of these two genotypes.

In 2013, at week 52 the total number of suspected cases recorded through the syndromic surveillance system, coordinated by the Lao Ministry of Health, exceeded 48000 cases with 95 deaths. Only nine of the twenty fatal cases investigated by the Institut Pasteur du Laos were confirmed positive for dengue infection. Among those positive for DENV-3 (n = 4), genotype II was found in three patients and genotype III in one patient.

Discussion

A dengue surveillance and alert system based on a weekly recording of dengue like syndroms has been in place in Lao PDR since 2006 but laboratory confirmation and dengue serotyping are only performed when the number of weekly cases exceeds the historical threshold. Even though a limited number of cases were analyzed yearly at the country level, this approach provided some preliminary data on predominant dengue serotypes over time [5]. However, as only few sequence data are available to date, it is nearly impossible to define the origin(s) of dengue strains, the dynamic of the serotypes and the mechanisms underlying the circulation of dengue in Lao PDR. In Vientiane capital, our network allowed following the proportions of dengue confirmed cases and of virus serotypes in real time. Initiatives of independent research groups started providing important information on dengue phylogeny [8]. Interestingly, these data obtained in a different context, (i.e. rural area, other dengue serotype 1) overlapped our observation of an active circulation of dengue virus during the dry season. From March 2013, the national network for dengue surveillance recorded a precocious and abnormally rapid increase of dengue cases in the provinces and in Vientiane capital until the epidemic subsided in October 2013. A total of 48772 dengue cases with 95 deaths were officially declared by the Lao Ministry of Health. The early and intense Southwest monsoon brought unusually heavy rains favoring the country-wide explosive emergence of dengue vector species (Ae. aegypti and Ae. albopictus), which could in part explain the importance and breadth of the 2013 epidemic. The second putative contributing parameter could have been a very low incidence of DENV-3 circulation at least during the past three years [5], [8], hence a more immunologically permissive environment for DENV-3 expansion. Retrospectively, in 2010 dengue 1 was predominant [8] whereas the year 2011 was marked by a low dengue activity. Indeed, in 2011only one DENV-3 isolate was detected in Vientiane capital through our surveillance network. Over the period studied (2010–2013), a very low genetic diversity was observed within both dengue 3 genotypes, supporting the hypothesis of a continuous local circulation of these strains. The putative introduction of DENV-3 genotype II isolates from Myanmar occurred probably before or during 2011. Genotype III was most likely introduced into Vientiane capital in late 2012 with no evidence of a previous circulation of this genotype in other Lao provinces. The patients with DENV-3 genotype III infections did not declare any travel aboard within the two weeks prior to symptom onset, but sequence comparisons support an Asian origin of the virus with close links to strains from India and Bhutan. Recent studies in India and China also point to the emergence of DENV-3 genotype III between 2009 and 2011 [9], [10]. In both cases, sequence comparison supports importation from Singapore or Vietnam, highlighting the diversity of dengue strain in Southeast Asia. Lao PDR is a landlocked country, becoming more and more a land-linked country sharing borders with five countries. This particular geographic situation may impact dengue epidemiology in that it may favor the cross boarder movement of viral isolates. A better understanding of DENV movement is now considered as a key point as emergence of new strains or genotypes have been associated with increased clinical severity [12], [13], [14]. Our study demonstrated that during the 2012–2013 epidemic, both DENV-3 genotypes II and III detected in Vientiane city were associated with death. We could not draw any statistical conclusion in terms of virulence as systematic genotyping has not yet been performed. The study of the dynamics of the two DENV-3 genotypes is still ongoing, however, it seems more likely that the serotype switch from DENV-1 to DENV-3 observed in June 2012, was the main event at the origin of the large scale 2013 epidemic in the Laotian capital. An update on the dengue surveillance in Lao PDR has been recently published [5]. Dengue serotypes proportions are provided for the last seven years at the country level, but regarding the total number of samples typed yearly, the significance of these data and their usefulness in terms of outbreak prediction are questionable. Fatal cases associated with dengue infections are rarely investigated in Laos like in most countries in Southeast Asia. Thus, the improvement of diagnostic capacities are requisite to better evaluate the real impact of dengue mortality particularly in the context of serotype switching and/or genotypes switching and viral virulence. Genotyping of dengue strains in Laos is in an early phase. Presently, there is no national biobank of isolates that could help establish the history of dengue serotypes and genotypes in Lao PDR. The identification of the co-circulation of multiple genotypes highlights the need to maintain efforts to understand the movement and dispersal of dengue strains throughout the Indochinese peninsula [3], [4], [5], [8], [9], [10], [11].

Acknowledgments

We thank all the medical staff of the hospital network in Vientiane capital for their active and motivated participation to the surveillance of dengue. We thank Antony Black for helpful discussion and manuscript revision.

Author Contributions

Conceived and designed the experiments: ML MG PTB P. Buchy VC KV. Performed the experiments: ML P. Bounmany MG KV. Analyzed the data: ML MG VC PTB P. Buchy VD. Contributed reagents/materials/analysis tools: JMH CV MT KC PV BO VC JMT MG VD. Wrote the paper: MG ML PTB VC JMT P. Buchy.

References

  1. 1. Undurraga EA, Halasa YA, Shepard DS (2013) Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis. PLoS Negl Trop Dis 7:e2056.
  2. 2. Gharbi M, Quenel P, Gustave J, Cassadou S, La Ruche G, et al. (2011) Time series analysis of dengue incidence in Guadeloupe, French West Indies: forecasting models using climate variables as predictors. BMC Infect Dis 11:166.
  3. 3. Vong S, Goyet S, Ly S, Ngan C, Huy R, et al. (2012) Under-recognition and reporting of dengue in Cambodia: a capture-recapture analysis of the National Dengue Surveillance System. Epidemiol Infect 140:491–9.
  4. 4. Huy R, Buchy P, Conan A, Ngan C, Ong S, et al. (2010) National dengue surveillance in Cambodia, 1980-2008: Insights on epidemiological and virological trends and impact of vector control intervention. Bull WHO 88:650–7.
  5. 5. Khampapongpane B, Lewis HC, Ketmayoon P, Phonekeo D, Somoulay V, et al. (2014) National dengue surveillance in the Lao People's Democratic Republic, 2006–2012: epidemiological and laboratory findings. Western Pac Surveill Response J 5:7–13.
  6. 6. Warrilow D, Northill JA, Pyke A, Smith GA (2002) Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes. J Med Virol 66:524–8.
  7. 7. Ito M, Takasaki T, Yamada K, Nerome R, Tajima S, et al. (2004) Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol 42:5935–7.
  8. 8. Dubot-Pérès A, Vongphrachanh P, Denny J, Phetsouvanh R, Linthavong S, et al. (2013) An epidemic of dengue-1 in a remote village in rural Laos. PLoS Negl Trop Dis 7:e2360.
  9. 9. Jiang T, Yu XD, Hong WX, Zhou WZ, Yu M, et al. (2012) Co-circulation of two genotypes of dengue virus serotype 3 in Guangzhou, China, 2009. Virol J 9:125
  10. 10. Gupta E, Mohan S, Bajpai M, Choudhary A, Singh G (2012) Circulation of Dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after Dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. J Vector Borne Dis 49:82–5.
  11. 11. Weaver SC, Vasilakis N (2009) Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 9:523–40.
  12. 12. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244–51.
  13. 13. Yamanaka A, Mulyatno KC, Susilowati H, Hendrianto E, Ginting AP, et al. (2011) Displacement of the predominant dengue virus from type 2 to type 1 with a subsequent genotype shift from IV to I in Surabaya, Indonesia 2008–2010. PLoS One 6:e27322.
  14. 14. Manakkadan A, Joseph I, Prasanna RR, Kunju RI, Kailas L, et al. (2013) Lineage shift in Indian strains of Dengue virus serotype-3 (Genotype III), evidenced by detection of lineage IV strains in clinical cases from Kerala. Virol J 10:37